SCM

Stonepine Capital Management Portfolio holdings

AUM $102M
1-Year Est. Return 40.04%
This Quarter Est. Return
1 Year Est. Return
+40.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
+$34.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
24
New
Increased
Reduced
Closed

Top Buys

1
+$9.22M
2
+$8.37M
3
+$5.24M
4
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
+$3.18M
5
APEN
Apollo Endosurgery, Inc.
APEN
+$3.06M

Top Sells

1
+$10.8M
2
+$5.52M
3
+$3.64M
4
ATRS
Antares Pharma, Inc.
ATRS
+$3.25M
5
DMAC icon
DiaMedica Therapeutics
DMAC
+$1.99M

Sector Composition

1 Healthcare 97.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$32.4M 24.83%
522,738
+7,373
2
$20.1M 15.35%
1,416,483
+651,247
3
$9.63M 7.37%
950,000
-196,470
4
$8.37M 6.4%
+69,939
5
$7.91M 6.05%
2,326,165
+900,730
6
$6.61M 5.06%
2,054,000
-1,714,597
7
$5.53M 4.23%
800,000
-1,562,240
8
$5.48M 4.19%
124,130
-26,083
9
$5.26M 4.03%
111,260
-76,928
10
$5.24M 4.01%
+685,000
11
$3.5M 2.68%
808,431
+150,964
12
$3.28M 2.51%
1,350,000
-574,956
13
$3.18M 2.44%
+379,470
14
$3.14M 2.4%
721,307
+371,307
15
$3.1M 2.37%
4,962,657
+578,458
16
$2.58M 1.97%
+167,333
17
$1.85M 1.42%
+15,550
18
$1.28M 0.98%
21,934
-13,833
19
$970K 0.74%
+16,667
20
$670K 0.51%
+1
21
$557K 0.43%
188,703
-400,794
22
– –
-272
23
– –
-1,205,501
24
– –
-284,730